The VICC.ORG Investigator Directory

Jeffrey A. Sosman, M.D.

Professor of Medicine (Hematology/Oncology)
Director, Melanoma & Tumor Immunotherapy Program
Co-Leader, VICC Signal Transduction & Cell Proliferation Research Program
VICC Member
Medical Oncologist

Patient Contact Information:

615-936-8422

Henry-Joyce Cancer Clinic
1301 Medical Center Drive, Suite 1710
Nashville, Tennessee 37232-7415
Phone: 615-936-8422 or 1-877-936-8422
Fax: 615-343-8668

Healthcare Provider Contact Information:

Division of Hematology/Oncology
2220 Pierce Avenue, 777 PRB
Nashville, TN 37232-6307
615-343-6653
Fax: 615-343-7602

Profile

Dr. Sosman directs the Melanoma Program (skin cancer) which is a highly integrated effort between oncology, dermatology, surgical oncology, and radiation oncology. This program provides patients with a thorough multi-disciplinary evaluation of their disease and cutting edge treatment options. Dr. Sosman's research includes studying skin cancers that are likely to recur and have no standard prevention treatment. He also compares chemotherapy agents (single and combined), and immunotherapy agents to determine their effects on treating skin cancers. One of Dr. Sosman's goals is to increase patient treatment options for skin cancer by studying new and investigational agents (not FDA approved), such as vaccines. He is also working on developing and establishing a new research program for the Vanderbilt-Ingram Cancer Center - Tumor Immunotherapy. In this capacity, he will study immunotherapy, cytokines and vaccine therapy for patients with malignancies other than melanoma such as renal cell carcinoma.

Education

  • M.D. - Yeshiva University, 1985
  • Fellowship - University of Chicago Medical Center, 1989
  • Residency - University of Wisconsin Hospital, 1987
  • Internship - University of Wisconsin Hospital, 1986

 

You do not have JavaScript enabled. This site works better with JavaScript turned on.